## VRSK: Verisk Analytics, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -1.4% below STRENGTH zone (4.0-10.0%); PEG 2.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($210.69)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. How Verisk Analytics Inc. (VRSK) Affects Rotational Strategy Timing**
- Source: Stock Traders Daily | 20251223T200000 | Neutral | Relevance: 100%
- This article analyzes Verisk Analytics Inc. (NASDAQ: VRSK) through an AI-driven lens, highlighting neutral readings in shorter horizons that could signify easing of a long-term weak bias. It outlines distinct institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss points based on multi-timeframe signal analysis. The analysis suggests an exceptional 46.0:1 risk-reward setup targeting a 13.3% gain with just 0.3% risk.

**2. Verisk Analytics, Inc. $VRSK Position Increased by Osaic Holdings Inc.**
- Source: MarketBeat | 20251224T105948 | Neutral | Relevance: 100%
- Osaic Holdings Inc. significantly increased its stake in Verisk Analytics, Inc. by 50.6% in the second quarter, now owning 15,454 shares valued at $4,805,000. Other institutional investors also adjusted their positions, with insider trading also noted: Director Sabra R. Purtill bought shares while CEO Lee Shavel sold some. Verisk Analytics reported strong Q3 earnings, beating analyst estimates, and announced a quarterly dividend of $0.45 per share.

**3. Riverbridge Partners LLC Has $78.04 Million Stake in Verisk Analytics, Inc. $VRSK**
- Source: MarketBeat | 20251222T130205 | Neutral | Relevance: 99%
- Riverbridge Partners LLC recently trimmed its stake in Verisk Analytics (NASDAQ:VRSK) by 1.5% to 310,275 shares, valued at $78.04 million. Despite this, other major institutional investors like Norges Bank, UBS, Goldman Sachs, and Arrowstreet Capital significantly increased their positions, collectively bringing institutional ownership to about 90%. Analysts maintain a "Hold" rating on Verisk Analytics, with an average price target of $278.64, while the company reported strong quarterly earnings and issued optimistic FY2025 guidance.

**4. Verisk (VRSK) Expands KYND Cyber Partnership: A Fresh Look at Whether the Stock’s Valuation Still Stacks Up**
- Source: Simply Wall Street | 20251225T001210 | Neutral | Relevance: 98%
- Verisk Analytics (VRSK) has strengthened its cyber risk intelligence offerings by expanding its partnership with KYND, integrating richer data into its Rulebook platform, amid increasing UK retail cyber vulnerabilities. Despite this strategic move and double-digit earnings growth, Verisk's recent share price performance has been weak, even though a "Most Popular Narrative" suggests the stock is 12.9% undervalued. The article questions whether Verisk is a mispriced compounder or if its growth story is already fully factored into its valuation, noting its high P/E ratio compared to the industry average.

**5. Q3 Earnings Roundup: Equifax (NYSE:EFX) And The Rest Of The Data & Business Process Services Segment**
- Source: Yahoo Finance | 20251223T090825 | Somewhat-Bearish | Relevance: 69%
- This article reviews the Q3 earnings for the data & business process services sector, highlighting strong revenue beats across the board and an average 4.8% stock increase since earnings reports. It details individual company performances, with Equifax (EFX) posting mixed results despite revenue growth, Planet Labs (PL) showing the strongest performance with significant revenue growth and analyst beats, and Verisk (VRSK) delivering the weakest results. The article also touches on market conditions, including recent interest rate cuts and a strong stock market performance in 2024.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $270 | $290 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.31M) |
| Sells | 5 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+2.0%)
- Blackrock Inc.: 9.4% (+5.5%)
- State Street Corpora: 4.3% (-1.3%)
- Alliancebernstein L.: 3.8% (+3.1%)
- FMR, LLC: 3.1% (-22.9%)

### Key Risks

1. Long-term trend broken: trading 18.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.68 signals overvaluation risk, limited margin of safety. Forward P/E 28.6x stretched relative to 10% growth. Quality metrics strong (ROE 268%, ROA 16%, margin 30%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $30.6B |
| Beta | 0.81 |
| 52W Range | $197.00 - $322.92 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.68 |
| Forward P/E | 28.6 |
| Current P/E | 31.5 |
| YoY Growth | 10.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.0% to -1.4% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Below SMA200 (0.81x), long-term trend not supportive. RSI neutral at 47. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.44% (CS: 35) | Neutral |
| RSI_14 | 46.7 | Neutral |
| MACD Histogram | 0.38 | Bullish |
| vs SMA20 | 0.995x | Below |
| vs SMA50 | 0.986x | Below |
| vs SMA200 | 0.811x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $218.85
- **Stop Loss:** $210.69 (3.7% risk)
- **Target:** $227.01 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 110
- **Position Value:** $24,073.50
- **Portfolio %:** 24.07%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-02-25 (Est: $1.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.70 | $1.72 | +1.0% |
| 2025Q2 | $1.77 | $1.88 | +6.1% |
| 2025Q1 | $1.68 | $1.73 | +2.8% |
| 2024Q4 | $1.60 | $1.61 | +0.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*